STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Arvinas to Present Virtually at the Goldman Sachs 41st Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

On June 5, 2020, Arvinas (Nasdaq: ARVN) announced Dr. Ron Peck, Chief Medical Officer, will speak at the Goldman Sachs 41st Annual Global Healthcare Conference on June 11 at 4:40 p.m. ET. A live audio webcast will be available here and on their website at www.arvinas.com.

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

NEW HAVEN, Conn., June 05, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Ron Peck, M.D., Chief Medical Officer, will participate in a fireside chat at the Goldman Sachs 41st  Annual Global Healthcare Conference on Thursday, June 11 at 4:40 p.m. ET.

A live audio webcast of the presentation will be available here and on the Company’s website at www.arvinas.com. A replay of the webcast will be archived on the Arvinas website for 30 days following the presentation.

About Arvinas
Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. The company has two clinical-stage programs: ARV-110 for the treatment of men with metastatic castrate-resistant prostate cancer; and ARV-471 for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer. For more information, visit www.arvinas.com.

Contacts for Arvinas

Investors
Will O’Connor, Stern Investor Relations
ir@arvinas.com

Media
Kirsten Owens, Arvinas Communications
kirsten.owens@arvinas.com


FAQ

When will Arvinas participate in the Goldman Sachs Healthcare Conference?

Arvinas will participate in the Goldman Sachs 41st Annual Global Healthcare Conference on June 11, 2020, at 4:40 p.m. ET.

Who is representing Arvinas at the Goldman Sachs Healthcare Conference?

Dr. Ron Peck, Chief Medical Officer of Arvinas, will represent the company.

How can I access the Arvinas presentation at the conference?

A live audio webcast of the presentation can be accessed here and on Arvinas' official website.

Will there be a replay of the Arvinas presentation?

Yes, a replay of the webcast will be archived on the Arvinas website for 30 days following the presentation.
Arvinas

NASDAQ:ARVN

ARVN Rankings

ARVN Latest News

ARVN Latest SEC Filings

ARVN Stock Data

708.18M
59.11M
6.85%
94.18%
11.67%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW HAVEN